The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Seravina O.F.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii Minzdrava Rossii, Moskva

Lisitsyna T.A.

Nauchno-issledovatel'skiĭ institut revmatologii RAMN

Starovoytova M.N.

V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia

Desinova O.V.

V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia

Kovalevskaia O.B.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii Minzdrava Rossii, Moskva

Vel'tishchev D.Iu.

Moskovskiĭ NII psikhiatrii

Chronic stress and mental disorders in patients with systemic scleroderma: Results of an interdisciplinary study

Authors:

Seravina O.F., Lisitsyna T.A., Starovoytova M.N., Desinova O.V., Kovalevskaia O.B., Vel'tishchev D.Iu.

More about the authors

Journal: Therapeutic Archive. 2017;89(5): 26‑32

Read: 8142 times


To cite this article:

Seravina OF, Lisitsyna TA, Starovoytova MN, Desinova OV, Kovalevskaia OB, Vel'tishchev DIu. Chronic stress and mental disorders in patients with systemic scleroderma: Results of an interdisciplinary study. Therapeutic Archive. 2017;89(5):26‑32. (In Russ.)
https://doi.org/10.17116/terarkh201789526-32

Recommended articles:
The gut microbiota in bipo­lar diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):28-33
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Como­rbidity of depression and deme­ntia: epidemiological, biological and therapeutic aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):113-121
Differentiated approach to cognitive reha­bilitation of patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):5-11
Cognitive impairment in bili­nguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61

References:

  1. Revmatologiya: klinicheskie re-komendatsii. Pod red. akad. RAMN E.L. Nasonova. 2-e izd. ispr. i dop. M.: GEOTAR-Media; 2010:523-557. (In Russ.)
  2. Cutolo M, Straub RH. Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation. 2006;13(5-6):277-282. doi:10.1159/000104855
  3. Сhen Y, Huang JZ, Qiang Y, Wang J, Han MM. Investigation of stressful life events in patients with systemic sclerosis. J Zhejiang Univ Sci B. 2008;9(11):853-856. doi:10.1631/jzus.B0820069
  4. Vasile M, Valesini G, Riccieri V. Acute Stress: Is it a Risk Factor for the Development of Systemic Sclerosis? Ann Rheum Dis. 2015;74:1137. doi:10.1136/annrheumdis-2015-eular.6067
  5. Lisitsina TA, Veltishchev DYu, Krasnov VN, Nasonov EL. Clinical and pathogenetic relationships between immuno-inflammatory rheumatic diseases and psychic disorders. Klinicheskaya meditsina. 2014;92(1):12-20. (In Russ.)
  6. Roca RP, Wigley FM, White B. Depressive symptoms associated with scleroderma. Arthrit Rheum. 1996;39(6):1035-1040. doi:10.1002/art.1780390623
  7. Waheed A, Hameed K, Khan AM, Syed JA, Mirza AI. The burden of anxiety and depression among patients with chronic rheumatologic disorders at a tertiary care hospital clinic in Karachi, Pakistan. J Pak Med Assoc. 2006;56(5):243-246.
  8. Thombs BD, Hudson M, Taillefer SS, Baron M. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthrit & Rheum. 2008;59(4):504-509. doi:10.1002/art.23524
  9. Mozzetta A, Antinone V, Alfani S, Neri P, Foglio Bonda PG, Pasquini P, Puddu P, Picardi A. Mental health in patients with systemic sclerosis: a controlled Investigation. J Eur Acad Dermatol Venereol. 2008;22(3):336-340. doi:10.1111/j.1468-3083.2007.02426.x
  10. Mura G, Krishna M Bhat, Pisano A, Licci G, Carta M. Psychiatric Symptoms and Quality of Life in Systemic Sclerosis. Clinical Practice & Epidemiology in Mental Health. 2012;8(1):30-35. doi:10.2174/1745017901208010030
  11. Baubet T., Ranque B, Taïeb O, Bérezné A, Bricou O, Mehallel S, Moroni Ch, Belin C, Pagnoux Ch, Moro M, Guillevin L, Mouthon L. Mood and anxiety disorders in systemic sclerosis patients. Presse Med. 2011;40:e111-e119. doi:10.1016/j.lpm.2010.09.019
  12. Baubet T, Brunet M, Garcia De La Peña-Lefebvre P, Taïeb O, Moro MR, Guillevin L, Mouthon L. Psychiatric manifestations of systemic sclerosis. Ann Med Interne. 2002;153(4):237-341.
  13. Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada S, Togashi R, Tada Y, Suzuki N, Nagasawa K. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol. 2003;30:1782-1787.
  14. Beretta L, Astori S, Ferrario E, Caronni M, Raimondi M, Scorza R. Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo. 2006;58(3):219-225. doi:10.4081/reumatismo.2006.219
  15. Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: A systematic review of the evidence. Arthrit Rheum. 2007;57(6):1089-1097. doi:10.1002/art.22910
  16. Thombs BD, Fuss S, Hudson M, Schieir O, Taillefer SS, Fogel J, Ford DE, Baron M. High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthrit Rheum. 2008;59(3):431-437. doi:10.1002/art.23328
  17. Benrud-Larson L.M., Haythornthwaite J. A., Heinberg L.J., Boling Ch, Reed J, White B, Wigley F. M. The impact of pain and symptoms of depression in scleroderma. Pain. 2002;95(3):267-275. doi:10.1016/s0304-3959(01)00409-2
  18. Danieli E, Airò P, Bettoni L, Cinquini M, Antonioli Ch.M., Cavazzana I, Franceschini F, Cattaneo R. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol. 2005;24:48-54. doi:10.1007/s10067-004-0970-z
  19. Bell C, Coupland N, Creamer P. Digital infarction in a patient with Raynaud's phenomenon associated with treatment with a specific serotonin reuptake inhibitor. A case report. Angiology. 1996;47:901-903. doi:10.1177/000331979604700909
  20. Coleiro B, Marshall SE, Denton CP, Howell K, Blann A, Welsh KI, Black CM. Treatment of Raynaud' s phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology Oxford. 2001;40(9):1038-1043. doi:10.1093/rheumatology/40.9.1038
  21. Hannestad J, Della Gioia N, Bloch M. The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis. Neuropsychopharmacology. 2011;36(12):2452-2459. doi:10.1038/npp.2011.132
  22. Masi AT. Subcommittee for scleroderma criteria of the American Rhеumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rhеum. 1980;23(5):581-590. doi:10.1002/art.1780230510
  23. Jordan S, Maurer B, Toniolo M, Michel B, Distler O. Performance of the new EULAR /ACR classification criteria for systemic sclerosis in clinical practice. Ann Rhеum Dis. 2013;72(Suppl.3):60. doi:10.1136/annrheumdis-2013-eular.239
  24. Valentini G, Silman AJ, Veale D. Assessment of disease activity. Clin Exp Rheumatol. 2003;21(3,Suppl.29):S39-S41.
  25. Montgomery SA, Asberg MA. New depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. doi:10.1192/bjp.134.4.382
  26. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-55. doi:10.1111/j.2044-8341.1959.tb00467.x
  27. Luriya AP. Vysshie korkovye funktsii cheloveka. Moskva; 1962. (In Russ.)
  28. Dragunskaya LS. Izuchenie priznakov depressivnykh sostoyanii metodom «Piktogrammy». Eksperimental'nye issledovaniya v patopsikhologii. M.; 1976:167-174. (In Russ.)
  29. Kovina TE, Kolechenko AK, Agafonova IN. Kommunikativnaya kul'tura i ee ekspertiza. Kom. po obrazovaniyu Sankt-Peterburga, S.-Peterb. un-t ped. masterstva. SPb.: B. i., 1996. (In Russ.)
  30. Zeigarnik BV. Narusheniya mysh-leniya u psikhicheski bol'nykh. M.; 1958. (In Russ.)
  31. Rubinshtein S Ya. Eksperimental'nye metodiki patopsikhologii i opyt primeneniya ikh v klinike. M.: 2004. (In Russ.)
  32. Zeigarnik BV. Patologiya mysh-leniya. M., 1962. (In Russ.)
  33. Heim C, Nemeroff С. The Role of Childhood Trauma in the Neurobiology of Mood and Anxiety Disorders: Preclinical and Clinical Studies. Biol Psychiatry. 2001;49(12):1023-1039. doi:10.1016/s0006-3223(01)01157-x
  34. Vel'tishchev DYu, Marchenko AS, Seravina OF, Kovalevskaya OB, Lisitsyna TA. Affektivno-stressovaya model' depressii: prakticheskoe vnedrenie v revma-tologicheskoi praktike. Psikhiatriya i psikhofarmakoterapiya. 2009;11(5):17-22. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.